Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB

Molecular and Cellular Biology

Volumn 15, Issue 3, 1995, Pages 1302-1311

  Didonato, Joseph A ^a   Mercurio, Frank ^b   Karin, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Signal Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; HELA CELL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 0028985190     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.15.3.1302     Document Type: Article

References (67)

1. Baeuerle, P. A. 1991. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072:63-80.
2. Baeuerle, P. A. 1991. The physiology of the NF-κB transcription factor, p. 423-446. In P. Cohen and J. G. Foulkes (ed.), The hormonal control regulation of gene transcription. Elsevier Science Publishers, Amsterdam.
3. Bartoli, G. M., A. Muller, E. Cadenas, and H. Sies. 1983. Antioxidant effect of diethyldithiocarbamate on microsomal lipid peroxidation assessed by low-level chemiluminescence and alkane production. FEBS Lett. 164:371-3744.
4. Beg, A. A., and A. Baldwin, Jr. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2064-2070.
5. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:3301-3310.
6. Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. Baldwin, Jr. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6:1899-1913.
7. Ben-Neriah, Y. Personal communication.
8. Blank, V., P. Kourilsky, and A. Israel. 1991. Cytoplasmic retention, DNA binding and processing of the NF-κB p50 precursor are controlled by a small region in its C-terminus. EMBO J. 10:4159-4167.
9. Blank, V., P. Kourilsky, and A. Israel. 1992. NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem. Sci. 17: 135-140.
10. Bose, H., Jr. 1992. The Rel family: models for transcriptional regulation and oncogenic transformation. Biochim. Biophys. Acta 1114:1-17.
11. Bours, V., P. R. Burd, K. Brown, J. Villalobos, S. Park, R. P. Ryseck, R. Bravo, K. Kelly, and U. Siebenlist. 1992. A novel mitogen-inducible gene product related to p50/p105-NF-κB participates in transactivation through a κB site. Mol. Cell. Biol. 12:685-695.
12. Bours, V., J. Villalobos, P. R. Burd, K. Kelly, and U. Siebealist. 1990. Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature (London) 348:76-80.
13. Boyle, W. J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110-149.
14. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκBα. Proc. Natl. Acad. Sci. USA 90:2532-2536.
15. Brownell, E., N. Mittereder, and N. R. Rice. 1989. A human rel protooncogene cDNA containing an Alu fragment as a potential coding exon. Oncogene 4:935-942.
16. Chiao, P. J., S. Miyamoto, and I. M. Verma. 1994. Autoregulation of IκBα activity. Proc. Natl. Acad. Sci. USA 91:28-32.
17. Cordle, S. R., R. Donald, M. A. Read, and J. Hawiger. 1993. Lipopolysaccharide induces phosphorylation of MAD-3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1 cells. J. Biol. Chem. 268:11803-11810.
18. Croall, D. E., and G. N. DeMartino. 1991. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol. Rev. 71:813-847.
19. Davis, N., S. Ghosh, D. L. Simmons, P. Tempst, H. C. Liou, D. Baltimore, and H. Bose, Jr. 1991. Rel-associated pp40: an inhibitor of the rel family of transcription factors. Science 253:1268-71.
20. Devary, Y., C. Rosette, J. A. DiDonato, and M. Karin. 1993. NF-κB activation by ultraviolet light not dependent on a nuclear signal. Science 261:1442-1445.
21. DiDonato, J. A. Unpublished observations.
22. Driscoll, J., and A. L. Goldberg. 1990. The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins. J. Biol. Chem. 265:4789-4792.
23. Eytan, E., D. Ganoth, T. Armon, and A. Hershko. 1989. ATP-dependent incorporation of 20S protease into the 26S complex that degrades proteins conjugated to ubiquitin. Proc. Natl. Acad. Sci. USA 86:7751-7755.
24. Fan, C. M., and T. Maniatis. 1991. Generation of p50 subunit of NF-κB by processing of p105 through an ATP-dependent pathway. Nature (London) 354:395-398.
25. Figueiredo-Pereira, M. E., N. Banik, and S. Wilk. 1994. Comparison of the effect of calpain inhibitors on two extralysosomal proteinases: the multicatalytic proteinase complex and m-calpain. J. Neurochem. 62:1989-1994.
26. Ghosh, S., and D. Baltimore. 1990. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature (London) 344:678-682.
27. Ghosh, S., A. M. Gifford, L. R. Riviere, P. Tempst, G. P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62:1019-1029.
28. Grilli, M., J. J. Chiu, and M. J. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
29. Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johannes, K. Mondal, P. Ralph, and A. Baldwin, Jr. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281-1289.
30. Hatada, E. N., A. Nieters, F. G. Wulczyn, M. Naumann, R. Meyer, G. Nucifora, T. W. McKeithan, and C. Scheidereit. 1992. The ankyrin repeat domains of the NF-κB precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-κB DNA binding. Proc. Natl. Acad. Sci. USA 89:2489-2493.
31. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of IκBα is necessary for activation of transcription factor NF-κB. Nature (London) 365:182-185.
32. Henkel, T., U. Zabel, K. van Zee, J. M. Muller, E. Fanning, and P. A. Baeuerle. 1992. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit. Cell 68:1121-1133.
33. Hirayama, M., Y. Kohgo, H. Kondo, N. Shintani, K. Fujikawa, K. Sasaki, J. Kato, and Y. Niitsu. 1993. Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron. Hepatology 18:874-880.
34. Hunter, T., and M. Karin. 1992. The regulation of transcription by phosphorylation. Cell 70:375-387.
35. Inoue, J., L. D. Kerr, D. Rashid, N. Davis, H. Bose, Jr., and I. M. Verma. 1992. Direct association of pp40/IκBβ with rel/NF-κB transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proc. Natl. Acad. Sci. USA 89:4333-4337.
36. Kerr, L. D., J. Inoue, N. Davis, E. Link, P. A. Baeuerle, H. Bose, Jr., and I. M. Verma. 1991. The rel-associated pp40 protein prevents DNA binding of Rel and NF-κB: relationship with IκBβ and regulation by phosphorylation. Genes Dev. 5:1464-1476.
37. Kieran, M., V. Blank, F. Logeat, J. Vandekerckhove, F. Lottspeich, O. Le Bail, M. B. Urban, P. Kourilsky, P. A. Baeuerle, and A. Israel. 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007-1018.
38. Mellits, K. H., R. T. Hay, and S. Goodbourn. 1993. Proteolytic degradation of MAD-3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res. 21:5059-5066.
39. Mercurio, F., J. DiDonato, C. Rosette, and M. Karin. 1992. Molecular cloning and characterization of a novel Rel/NF-κB family member displaying structural and functional homology to NF-κB p50/p105. DNA Cell Biol. 11:523-537.
40. Mercurio, F., J. A. DiDonato, C. Rosette, and M. Karin. 1993. p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev. 7:705-718.
41. Meyer, R., E. N. Hatada, H. P. Hohmann, M. Haiker, C. Bartsch, U. Rothlisberger, H. W. Lahm, E. J. Schlaeger, A. P. van Loon, and C. Scheidereit. 1991. Cloning of the DNA-binding subunit of human nuclear factor κ B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor α. Proc. Natl. Acad. Sci. USA 88:966-970.
42. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326:711-713.
43. Neri, A., C. C. Chang, L. Lombardi, M. Salina, P. Corradini, A. T. Maiolo, R. S. Chaganti, and R. Dalla-Favera. 1991. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell 67:1075-1087.
44. Nolan, G. P., S. Ghosh, H. C. Liou, P. Tempst, and D. Baltimore. 1991. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64:961-969.
45. Orlowski, M. Personal communication.
46. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor and the activation of NF-κB. Cell 78:773-785.
47. Powers, J., and J. Harper. 1986. Inhibitors of serine proteinases, p. 55-152. In A. J. Barrett and G. Salvensen (ed.), Proteinase inhibitors. Elsevier Science Publishers, Amsterdam.
48. Rice, N. R., and M. K. Ernst. 1993. In vivo control of NF-κB activation by IκBα. EMBO J. 12:4685-4695.
49. Rice, N. R., M. L. MacKichan, and A. Israel. 1992. The precursor of NF-κB p50 has IκB-like functions. Cell 71:243-253.
50. Rich, D. H. 1986. Inhibitors of cysteine proteinases, p. 153-178. In A. J. Barrett and G. Salvensen (ed.), Proteinase inhibitors. Elsevier Science Publishers, Amsterdam.
51. Rosette, C., and M. Karin. Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-κB. J. Cell Biol., in press.
52. Ruben, S. M., P. J. Dillon, R. Schreck, T. Henkel, C. H. Chen, M. Maher, P. A. Baeuerle, and C. A. Rosen. 1991. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB. Science 251: 1490-1493.
53. Ryseck, R. P., P. Bull, M. Takamiya, V. Bours, U. Siebenlist, P. Dobrzanski, and R. Bravo. 1992. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12:674-84.
54. Saatcioglu, F., T. Deng, and M. Karin. 1993. A novel cis element mediating ligand-independent activation by c-ErbA: implications for hormonal regulation. Cell 75:1095-1105.
55. Schmid, R. M., N. D. Perkins, C. S. Duckett, P. C. Andrews, and G. J. Nabel. 1991. Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65. Nature (London) 352:733-736.
56. Schoellmann, G., and E. Shaw. 1963. Direct evidence for the presence of histidine in the active center of chymotrypsin. Biochemistry 2:252-255.
57. Sen, R., and D. Baltimore. 1986. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 47:921-928.
58. Shirakawa, F., and S. B. Mizel. 1989. In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol. Cell. Biol. 9:2424-2430.
59. Stopeck, A. T., A. C. Nicholson, F. P. Mancini, and D. P. Hajjar. 1993. Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. J. Biol. Chem. 268:17489-17494.
60. Sun, S. C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259:1912-1915.
61. Suzuki, K., T. C. Saido, and S. Hirai. 1992. Modulation of cellular signals by calpain. Ann. N. Y. Acad. Sci. 674:218-227.
62. Tewari, M., P. Dobrzanski, K. L. Mohn, D. E. Cressman, J. C. Hsu, R. Bravo, and R. Taub. 1992. Rapid induction in regenerating liver of RL/IF-1 (an IκB that inhibits NF-κB, RelB-p50, and c-Rel-p50) and PHF, a novel κB site-binding complex. Mol. Cell. Biol. 12:2898-2908.
63. Thompson, C. C., T. A. Brown, and S. L. McKnight. 1991. Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex. Science 253:762-768.
64. Tsujinaka, T., Y. Kajiwara, J. Kambayashi, M. Sakon, N. Higuchi, T. Tanaka, and T. Mori. 1988. Synthesis of a new cell penetrating calpain inhibitor (calpeptin). Biochem. Biophys. Res. Commun. 153:1201-1208.
65. Vinitsky, A., C. Michaud, J. C. Powers, and M. Orlowski. 1992. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. Biochemistry 31:9421-9428.
66. Wang, K. K. 1990. Developing selective inhibitors of calpain. Trends Pharmacol. Sci. 11:139-142.
67. Zabel, U., T. Henkel, M. S. Silva, and P. A. Baeuerle. 1993. Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J. 12:201-211.